About PsychoGenics
With comprehensive translational services that deliver on your needs, we’re dedicated to driving your progress so you can discover the next generation of breakthrough CNS therapies.
Where Passion Powers CNS Drug Discovery
Teamwork. Excellence. Creativity. Entrepreneurial spirit.
The Proven Power of Experience
years of experience
client relationships with more than 70% of clients returning
%
team members with a Ph.D
disease models
behavioral assays
Our Latest Updates
-
View By:
- News
- Resources
- Events
PsychoGenics Awarded an NIH Contract to Test and Identify Novel Therapeutics for Pain
PARAMUS, N.J., October 8, 2024 –– PsychoGenics Inc. (PsychoGenics) today announced it has been awarded a contract by the National Institutes of Health (NIH) to test and identify novel investigational therapeutics for the treatment of pain. The lack of safe and...
PsychoGenics Inc. Awarded $3 million SBIR Grant to Employ its AI-enabled Platforms to Find Treatments for Rare Disorders
PARAMUS, NEW JERSEY, August 28, 2024 - PsychoGenics, a leader in AI-enabled phenotypic drug discovery, has been awarded a Fast Track Small Business Innovation Research (SBIR) grant by NIMH, worth up to $3 million over four years. This grant will support PsychoGenics...
Back to the future: From target-selective drug design to AI-enabled polypharmacology
ASD Models – Shank3/F, Cntnap2-KO, Fmr1-KO
Autism spectrum disorders (ASDs) describe a broad category of neurodevelopmental disorders that can pose challenges to an individual’s health over a lifetime. The severity and specificity of clinical features of ASDs can vary from individual to individual,...
Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats
Johana Bastidas1, Karina Szyba1, Maria Ketchel1, Allison Greenyer1, Jose Beltran1, Jodi Gresack1, Afshin Ghavami11 PsychoGenics Inc., Paramus, NJ, US Stroke is a leading cause of death and long-term disability worldwide, withischemic stroke accounting for...
Spotlight on Our Tuberous Sclerosis Complex (TSC) Research and the Tsc2 KO Mouse Model
Tuberous sclerosis complex (TSC) is a genetic disorder that causes non-malignant tumors to form in many different organs, primarily in the brain, eyes, heart, kidney, skin, and lungs. Changes in the brain caused by TSC have the biggest impact on quality of life, from...
Explore PsychoGenics
About Us
Leadership Team
About Us
Culture
About Us